News Image

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

Provided By GlobeNewswire

Last update: Oct 28, 2025

Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA™ FENTANYL (abuse deterrent transdermal system) through commercialization.

Read more at globenewswire.com

NUTRIBAND INC

NASDAQ:NTRB (11/7/2025, 12:32:21 PM)

5.66

+0.13 (+2.35%)


NUTRIBAND INC -CW26

NASDAQ:NTRBW (11/5/2025, 8:17:37 PM)

2.1

-0.51 (-19.54%)



Find more stocks in the Stock Screener

Follow ChartMill for more